Polypectomy Techniques, Endoscopist Characteristics, and Serious Gastrointestinal Adverse Events by Chukmaitov, Askar S. et al.
Virginia Commonwealth University
VCU Scholars Compass
Healthcare Policy and Research Publications Dept. of Healthcare Policy and Research
2014
Polypectomy Techniques, Endoscopist
Characteristics, and Serious Gastrointestinal
Adverse Events
Askar S. Chukmaitov
Virginia Commonwealth University, achukmaitov@vcu.edu
Cathy J. Bradley
Virginia Commonwealth University, cjbradley@vcu.edu
Bassam Dahman
Virginia Commonwealth University, bdahman@vcu.edu
See next page for additional authors
Follow this and additional works at: http://scholarscompass.vcu.edu/hcpr_pubs
Part of the Medicine and Health Sciences Commons
© 2014 Wiley Periodicals, Inc. This is the peer reviewed version of the following article: Chukmaitov, A., Bradley, C. J.,
Dahman, B., Siangphoe, U., BouHaidar, D. and Warren, J. L. (2014), Polypectomy techniques, endoscopist
characteristics, and serious gastrointestinal adverse events. J. Surg. Oncol., 110: 207–213, which has been published in
final form at doi: 10.1002/jso.23615. This article may be used for non-commercial purposes in accordance With Wiley
Terms and Conditions for self-archiving.
This Article is brought to you for free and open access by the Dept. of Healthcare Policy and Research at VCU Scholars Compass. It has been accepted
for inclusion in Healthcare Policy and Research Publications by an authorized administrator of VCU Scholars Compass. For more information, please
contact libcompass@vcu.edu.
Downloaded from
http://scholarscompass.vcu.edu/hcpr_pubs/6
Authors
Askar S. Chukmaitov, Cathy J. Bradley, Bassam Dahman, Umaporn Siangphoe, Doumit BouHaidar, and Joan
L. Warren
This article is available at VCU Scholars Compass: http://scholarscompass.vcu.edu/hcpr_pubs/6
1 
 
Title: Polypectomy Techniques, Endoscopist Characteristics, and Serious Gastrointestinal 
Adverse Events. 
 
 
Askar Chukmaitov, M.D., Ph.D. (corresponding author) 
Department of Healthcare Policy and Research 
Virginia Commonwealth University 
Richmond, VA 23298-0430 
achukmaitov@vcu.edu  
 
Cathy J. Bradley, Ph.D. 
Department of Healthcare Policy and Research 
School of Medicine, Virginia Commonwealth University 
Richmond, VA 
cjbradley@vcu.edu 
 
Bassam Dahman, Ph.D. 
Department of Healthcare Policy and Research 
School of Medicine, Virginia Commonwealth University 
Richmond, VA 
bdahman@vcu.edu 
 
Umaporn Siangphoe, M.S. 
Department of Healthcare Policy and Research 
School of Medicine, Virginia Commonwealth University 
Richmond, VA 
siangphoeu@vcu.edu 
 
Doumit BouHaidar, M.D., AGAF 
Associate Professor of Medicine 
Director, Advanced Therapeutic Endoscopy 
Division of Gastroenterology 
Virginia Commonwealth University 
Email dsbouhaidar@vcu.edu 
 
Joan L. Warren, Ph.D.  
Health Services and Economics Branch  
National Cancer Institute  
Bethesda, MD 
warrenj@mail.nih.gov 
 
© 2014 Wiley Periodicals, Inc. This is the peer reviewed version of the following article: Chukmaitov, A., Bradley, 
C. J., Dahman, B., Siangphoe, U., BouHaidar, D. and Warren, J. L. (2014), Polypectomy techniques, endoscopist 
characteristics, and serious gastrointestinal adverse events. J. Surg. Oncol., 110: 207–213, which has been published 
in final form at doi: 10.1002/jso.23615. This article may be used for non-commercial purposes in accordance With 
Wiley Terms and Conditions for self-archiving. 
 
2 
 
Synopsis:   
 
A use of polypectomy techniques and the odds of serious gastrointestinal adverse events vary by 
endoscopist specialty (i.e., primary care, surgery, and gastroenterology) and for low-, medium-, 
and high-volume providers.  Simple cold biopsy forceps appeared to be safe for the use by all 
types of endoscopists.  For primary and single hot biopsy forceps/ablation or snare polypectomy, 
high-volume endoscopists may be preferred providers; and gastroenterologists or surgeons may 
be best fit to provide complex polypectomy procedures.   
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Abstract: 
 
Background: A use of polypectomy techniques by endoscopist specialty (primary care, surgery, 
and gastroenterology) and experience (volume), and associations with serious gastrointestinal 
adverse events, were examined.  
Methods: A retrospective follow-up study with ambulatory surgery and hospital discharge 
datasets from Florida, 1999-2001, was used.  Thirty-day hospitalizations due to colonic 
perforations and gastrointestinal bleeding were investigated for 323,585 patients. 
Results:  Primary care endoscopists and surgeons used hot biopsy forceps/ablation, while 
gastroenterologists provided snare polypectomy or complex colonoscopy.  Low-volume 
endoscopists were more likely to use simpler rather than complex procedures.  For hot 
forceps/ablation and snare polypectomy, low- and medium-volume endoscopists reported higher 
odds of adverse events.  For complex colonoscopy, higher odds of adverse events were reported 
for primary care endoscopists (1.74 [95%CI, 1.18 to 2.56]) relative to gastroenterologists 
Conclusions:  Endoscopists regardless of specialty and experience can safely use cold biopsy 
forceps. For hot biopsy and snare polypectomy, low volume, but not specialty, contributed to 
increased odds of adverse events.  For complex colonoscopy, primary care specialty, but not low 
volume, added to the odds of adverse events. Comparable outcomes were reported for surgeons 
and gastroenterologists.  Cross-training and continuing medical education of primary care 
endoscopists in high-volume endoscopy settings are recommended for complex colonoscopy 
procedures. 
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Background (Word Count – 3,038) 
Colorectal cancer (CRC) remains one of the most common cancers and causes of cancer 
mortality in the United States [1,2].  The expenditures for treatment of CRC were approximately 
$8.4 billion in 2004 [3].  CRC is preventable through removal of premalignant polyps, which 
makes colonic polypectomy a preferred method of CRC prevention [2]. The number of 
colonoscopies is approximately14 million per year [4]. The demand for colonoscopy is expected 
to grow due primarily to the aging population in the U.S [4]. Advances in technology and 
inclusion of gastrointestinal (GI) endoscopy in training of primary care physicians and surgeons 
allowed generalists to provide colonoscopy procedures that used to be in the realm of 
gastroenterologist care [5].  A shortfall of up to 1,550 gastroenterologists is estimated by 2020 
[6] and as such, the role of primary care physicians and surgeons in providing CRC prevention 
services including colonoscopy is likely to remain unchanged over time.  In the era of health 
reform with its focus on improvement of quality of care, cost containment, and population 
health, both specialists and generalists need to demonstrate the value and quality of care [7], 
particularly when it is relevant to cancer prevention.  
Previous research has generally favored specialists over generalists for quality of care 
across various conditions [8].  Research findings on the endoscopist specialty, quality of 
colonoscopy, and patient outcomes were mixed [7].  No difference among gastroenterologists 
and family physicians in the proportion of cecal intubation and polyp detection rates for 
colonoscopy patients was reported [7].  One study favored gastroenterology over surgical 
trainees for colonoscopy completion rates and adenoma detection rates [9].  The risk of post-
colonoscopy CRC was higher for primary care endoscopists in comparison with surgeons and 
gastroenterologists suggesting that primary care endoscopists were more likely to miss or leave 
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residual polyps during colonoscopy [10]. Endoscopist experience that was operationalized as an 
annual volume of procedures may affect patient outcomes, as previous research favored high-
volume over low-volume endoscopists in terms of the risks of adverse gastrointestinal (GI) 
events due to colonoscopy [11,12].  
Screening and diagnostic colonoscopy procedures are relatively safe; however, outpatient 
polypectomy is associated with a nine-fold increase in risks of serious adverse events, such as 
colonic perforations and GI bleeding that require inpatient admission, in comparison with 
colonoscopy without polypectomy [13]. Prior research also discovered that as complexity of 
polypectomy increased, a higher risk of serious GI adverse events was reported [12]. While 
gastroenterologists’ use of polypectomy techniques is highly variable for polyps of similar sizes 
[14], a preferred polypectomy technique is not yet identified [12-15]. Primary care endoscopists 
tend to use less complex GI procedures and select healthier patients with lower severity of illness 
and less comorbidities [5]. As such, the risks of serious GI adverse events due to polypectomy 
may depend on the endoscopist specialty and experience [9,12], a specific polypectomy 
technique [12], clinical factors (e.g., severity of illness, polyp size and type) [16], and patient 
characteristics (e.g., age, comorbidities) [17].  
With a growing emphasis on quality and efficiency of colonoscopy for CRC prevention, 
the debate about the use of polypectomy and the value of endoscopist specialty and experience 
may intensify.  However, a lack of data on a preferential use of specific polypectomy techniques 
by endoscopist specialty and experience, as well as its impact on the rates of serious GI adverse 
events, leaves a substantial gap in the literature.  In addition, previous research on the efficiency 
and effectiveness of care provided by generalists versus specialists was criticized for 
methodological shortcomings such as failures to account for confounding factors of physician 
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experience, practice settings, severity of illness and comorbidity in the patient populations [8].  
We study a preferential use of polypectomy techniques by endoscopist specialty (primary 
care, surgery, and gastroenterology) and experience (volume), and their associations with serious 
gastrointestinal adverse events.  This study accounts for differences in practice settings and uses 
a validated method of risk adjustment for both severity of illness and comorbid diagnoses.  This 
study uses a large, encounter-level, and all payer dataset with patient and physician identifiers for 
all Florida ambulatory surgery centers (ASC), hospital-based outpatient departments (HOPD), 
and hospitals to identify hospitalizations for serious GI adverse events due to colonic 
perforations and GI bleeding within 30 days after colonoscopy.  These data covered the entire 
population of Florida that was treated in the outpatient surgery setting.  Another unique feature 
of these databases is that they included operating physicians’ identification numbers and 
specialty codes important for construction of key endoscopist measures for the period 1999 – 
2001.  Even though the study uses historic data, it provides an important baseline research, as it 
is the first study investigating associations among the main polypectomy techniques that are 
currently in use and endoscopist specialty, experience, and patient outcomes.  As such, the study 
findings are useful for future research and policy-making on polypectomy guidelines, post-
graduate and continuing medical education in endoscopy, and CRC prevention. 
Methods 
 
Data Sources:  
  Ambulatory surgery and inpatient hospital discharge datasets were obtained from the 
Florida Agency for Health Care Administration for 1999 through 2001. Both datasets were at the 
encounter-level and included unique patient identifiers, primary and secondary diagnoses as 
classified by the International Classification of Diseases, Ninth Revision, Clinical Modification 
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(ICD-9-CM), primary and secondary procedure codes based on Current Procedural Terminology 
(CPT), payer types, facility types, dates of outpatient procedures and hospitalizations, and patient 
demographic characteristics.  Polypectomy procedures were linked to subsequent 
hospitalizations to identify all hospital admissions for serious GI adverse events within 30 days.  
Figure 1 describes how the analytical sample of 323,585 polypectomy procedures provided by 
860 endoscopists was derived for 1999-2001 as the unique (and consistent over time) physician 
identification numbers (UPIN) and the CMS physician specialty codes were available only for 
this period.   
 
Figure 1. Description of Analytical Sample 
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Dependent Variables 
Polypectomy Procedures:   
Four polypectomy categories were constructed using the CPT codes [18].  Cold biopsy 
forceps were identified via primary CPT 45380 code for single or multiple biopsies and defined 
as the simple polypectomy [18].  Two categories of polypectomy techniques were constructed 
using primary CPT codes and identified as single polypectomy types: (1) hot biopsy forceps or 
bipolar cautery (CPT 45384) and ablation of lesion(s) not amendable to removal by hot biopsy 
forceps, bipolar cautery, or snare techniques (CPT 45383), combined into one category; and (2) 
snare polypectomy (CPT 45385) [18]. The complex colonoscopy was where multiple 
colonoscopy procedures were performed, and primary and secondary CPT codes with any 
combination of procedures with cautery, control of bleeding, injections, and/or tattooing  (CPT 
45380, 45381, 45382, 45383, 45384, and/or 45385) were billed during the same session [18]. A 
use of these techniques was highly variable for removing polyps of similar sizes [14].  
Endoscopists currently use these main polypectomy techniques [14] that are also identifiable in 
administrative databases [18].   
 
Serious Adverse Events: 
The primary patient outcome was a cumulative measure of hospitalizations due to colonic 
perforation and/or GI bleeding within 30 days of a polypectomy that is procedure specific [16] 
and potentially reflective of endoscopist skills [11-12]. Primary diagnosis codes in the inpatient 
hospital discharge dataset were used to identify colonic perforations [ICD-9-CM: 569.83, 998.2], 
GI bleeding [ICD-9-CM: 578.1, 578.9, 998.1], acute postheomorrhagic anemia [ICD-9-CM: 
285.1], and blood transfusion [ICD-9-CM: 280-284.9, 285.2-285.9, 99.03, 99.04].   
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Key Explanatory Variables  
Endoscopist Specialty: 
 Endoscopist specialty categories were defined via the CMS specialty codes as: (1) 
primary care (i.e., family practice, geriatric medicine, internal medicine, general practice, 
obstetrics/gynecology, or preventive medicine), (2) surgery (i.e., thoracic surgery; surgical 
oncology, vascular surgery, general surgery, or colorectal surgery), and (3) gastroenterology.  
 
Endoscopist Polypectomy Volume:  
The annual polypectomy volume for each endoscopist was calculated as the total number 
of primary polypectomy procedures in each year of the study.  Physicians were assigned to low 
(less than 150 cases per year), medium (150-299 cases per year), or high (more than or equal to 
300 cases per year) volume categories based on annual volume of all polypectomy procedures.  
Providers’ volume was allowed to vary from year to year. The annual volume is often use as a 
measure of provider experience [19].  
 
Endoscopist Polypectomy Rate and Repeat Endoscopy: 
A polypectomy rate (PR) for each endoscopist was calculated as a proportion of snare 
polypectomy, hot biopsy, and cold biopsy procedures that had the ICD-9 code of 211.3 for polyp 
detection to all diagnostic and polypectomy colonoscopies for the study period (1999-2001) [20]. 
We calculated the PR separately for each physician identifier and calendar year on a sample 
(n=560,119) before exclusion of simple (i.e., diagnostic) procedures (Figure 1).  The PR 
calculated form administrative claims data are validated against adenoma detection rates (ADR) 
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derived from endoscopy reports [20]. The PR is an accurate surrogate for the ADR [20]. A PR of 
35% is needed to achieve a recommended ADR benchmark of 20% [20]. We included the PR as 
a covariate reflecting experience of endoscopists in detecting adenomas. 
Following the surveillance guidelines [21], a measure of repeat endoscopy was 
constructed as an indicator variable when any type of colonoscopy procedures was provided to 
the same patient within 12 months of an initial polypectomy.  The measure of repeat endoscopy 
was used as a covariate in multivariate logistic regression models to account for removal of large 
sessile adenomas (that were likely removed piecemeal) at a shorter interval and required 
individualized surveillance of patients by experienced endoscopists [21].  
 
Control Variables: 
A dichotomous variable representing facility type was included to identify facility types 
as ASC or HOPD, where the majority of polypectomy procedures usually take place.  Patient age 
was categorized as: 19 – 49, 50 – 64, 65 – 74, 75 – 84, and > 85 years old.  Race/ethnicity was 
specified as: white, Hispanic, black or African American, or other (including unknowns).  
Gender was included as a binary variable.  Health insurance types were categorized as Medicare, 
Medicare HMO, Medicaid, Medicaid HMO, commercial Indemnity, commercial Health 
Maintenance Organizations (HMO), commercial Preferred Provider Organizations (PPO), self-
pay or charity, and other.  Diagnostic cost groups/hierarchical condition categories (DCG/HCC), 
which used all available ICD-9-CM diagnostic codes to categorize patients, were used to 
incorporate all comorbid conditions and indicate a greater severity of illness among patients with 
higher risk scores [22-24]. Finally, unobserved changes over time common for both ASCs and 
HOPDs (e.g., changes in practice guidelines, new policy recommendations) were controlled by 
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including a set of dummy variables for each year between 1999 and 2001. 
Statistical analysis: 
Polypectomy procedures, provider, and patient characteristics were examined by 
endoscopist specialty using univariate tests. Unadjusted rates for serious GI adverse events were 
calculated by dividing the total numbers of adverse events by the total number of procedures for 
specific polypectomy types by endoscopist specialty. Wald tests of linear restrictions were used 
for descriptive analyses.  
Multivariate logistic regression models were used to predict the preferential use of 
polypectomy procedures (with each polypectomy category as a dependent variable) for 
endoscopists specialized in primary care, surgery, or gastroenterology (referent) and those in 
low-, medium-, and high-volume (referent) categories. In a separate set of multivariate analyses 
with serious GI adverse events as the dependent variable, polypectomy categories were used for 
stratification, to predict the adjusted odds of adverse events for each endoscopist specialty and 
volume categories as described above.  
Odds ratios were estimated to evaluate the magnitude and direction of the effect for the 
key parameters of interest, after adjusting for the contributions of other covariates: 2 facility 
types with HOPD as the reference; 5 patient age categories with 19 – 49 as the reference; 4 
race/ethnicity categories with white as the reference; gender with male as the reference; 4 health 
insurance types with Medicare as the reference; patient severity of illness measured as 
continuous risk scores; and variables for each year with 1999 as the reference. 
As the univariate tests were exploratory and meant to highlight differences, their 
significant results were not subjected to any corrections for multiple testing. The results from the 
multivariate analyses are most definitive. There are no corrections for multiple testing to their 
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results, as these findings are to be taken as suggestive only due to the source and nature of the 
data, with their inherent limitations. We tested for multicollinearity, correlations, and interactions 
between covariates. Statistical significance was determined at p < 0.05. The university 
institutional review board approved the study. 
All data were collected in 2006, and the current analysis was conducted in 2013.  There is 
a time lag of several years for organizing claims data into analytical files and making them 
available to researchers.  We obtained these data from the Florida Agency for Health Care 
Administration to study comparative effectiveness of ASCs and HOPDs.  Once that analysis was 
complete, the research team turned to other topics of interest including the one presented in this 
paper. When using claims data, a lag of several years is not unusual.  
 
Results 
Descriptive analyses: 
Gastroenterologists represented the majority of endoscopists (n=528, 61.4%) (Table 1). 
There were 153 (17.8%) primary care providers of polypectomies, specializing in internal 
medicine (n=107, 69.9%), family medicine (n=33, 21.6%), general practice (n=8, 5.2%) and 
obstetrics/gynecology (n=5, 3.3%). Surgeons (n=179, 20.8%) specializing in general surgery 
(n=137, 76.5%), colon/rectal surgery (n=37, 20.7%), and other types of surgery (n=5. 2.8%). 
Less than 1% of polypectomy procedures resulted in serious GI adverse events.  Adverse events 
by specialty categories were not statistically different for primary care (0.43%), surgery (0.39%), 
and gastroenterology (0.35%). Primary care endoscopists provided higher proportions of cold 
biopsy procedures than surgeons and gastroenterologists.  Surgeons used more of hot 
biopsy/ablation procedures in comparison with primary care physicians and gastroenterologists.  
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Gastroenterologists primarily performed snare polypectomy and complex colonoscopy 
procedures.  Surgeons performed more polypectomy procedures in a hospital-based setting rather 
than in ASCs.  Gastroenterologists performed a higher mean volume of polypectomy procedures 
(n=321) in comparison with primary care endoscopists (n=200) and surgeons (n=180).  A 
polypectomy rate was lower for surgeons (0.33) than for primary care endoscopists (0.39) and 
gastroenterologists (0.38). Table 1 also reports patient characteristics by endoscopist specialties 
that were primarily similar across endoscopist specialties. Primary care endoscopists treated 
higher proportions of minorities and patients covered by Medicare HMO, Medicaid, self-
pay/charity, and other payers.  Different types of endoscopists provided polypectomies to 
patients with comparable severity of illness (Table 1). 
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Table 1. Serious GI Adverse Events, Procedure, Provider, and Patient Characteristics by 
Endoscopist Specialty 
***: p<0.01  
 Primary Care Surgery Gastroenterology  Total P-value 
Number of endoscopists (%) 153 (17.79) 179 (20.81) 528 (61.4) 860 (100) *** 
Serious GI adverse events, n (%) 99 (8.43) 90 (7.67) 985 (83.90) 1,174 (100) *** 
Unadjusted rate of AE (%)  0.43 0.39 0.35 0.36  
Polypectomy procedures (%) 22,797 (7.05) 23,019 (7.11) 277,769 (85.84) 323,585 (100) *** 
Total number of procedures 39,165 (6.70) 45,518 (8.13) 475,422 (84.88) 560,105 (100) *** 
Repeat endoscopy (%) 415 (1.82) 588 (2.55) 5,566 (2.00) 6,569 (2.03) *** 
      
Polypectomy Procedures:      
Cold biopsy forceps 5,728 (25.13) 3,723 (16.17) 63,700 (22.93) 73,151 (22.61) *** 
Hot biopsy forceps/Ablation  7,728 (33.90) 9950 (43.23) 80,808 (29.09) 98,486 (30.44) *** 
Snare polypectomy 6,252 (27.42) 5886 (25.57) 87,638 (31.55) 99,776 (30.83) *** 
Complex Colonoscopy 3,089 (13.55) 3,460 (15.03) 45,623 (16.42) 52,172 (16.12) *** 
      
Provider Characteristics:      
Endoscopist Volume, mean (SD)  200 (154) 180 (163) 321 (238) 302 (233) *** 
 
Volume Category,  mean (SD)     *** 
< 150 78 (44) 67 (40) 99 (37) 91 (41)  
150 - 299 208 (40) 231 (42) 224 (42) 223 (42)  
> 300 454 (104) 506 (114) 514 (256) 511 (249)  
Polypectomy rate, mean (SD) 0.392 (0.23) 0.326 (0.21) 0.381 (0.16) 0.372 (0.19) *** 
ASCs, n (%) 11,185 (49.06) 9,827 (42.69) 139,003 (50.04) 160,015 (49.45) *** 
HOPDs,  n (%) 11,612 (50.94) 13,192 (57.31) 138,766 (49.96) 163,570 (50.55)  
      
Patient Characteristics:      
Age categories, years, n (%):      
19 – 49 3,295 (14.45) 3,087 (13.41) 40,851 (14.71) 47,233 (14.60) *** 
50 – 64 7,182 (31.50) 6,599 (28.67) 87,448 (31.48) 101,229 (31.28) *** 
65 – 74 6,913 (30.32) 7,354 (31.95) 84,536 (30.43) 98,803 (30.53) *** 
75 – 84 4,691 (20.58) 5,178 (22.49) 56,342 (20.28) 66,211 (20.46) *** 
> 85 716 (3.14) 801 (3.48) 8,592 (3.09) 10,109 (3.12) *** 
Gender, n (%):      
Male 11,278 (49.47) 12,793 (55.58) 138,363 (49.81) 162,434 (50.2) *** 
Female 11,519 (50.53) 10,226 (44.42) 139,406 (50.19) 161,151 (49.8)  
Race, n (%):      
White 17,593 (77.17) 19,035 (82.69) 233,523 (84.07) 270,151 (83.49) *** 
Hispanic 2,637 (11.57) 1,658 (7.20) 14,411 (5.19) 18,706 (5.78) *** 
Black/African  American 1,244 (5.46) 764 (3.32) 10,962 (3.95) 12,970 (4.01) *** 
Other/unknown 1,323 (5.80) 1,562 (6.79) 18,873 (6.79) 21,758 (6.72) *** 
Severity of Illness: 
Risk Score, mean (SD) 1.45 (0.7) 1.44 (0.67) 1.44 (0.69) 1.44 (0.69) 
 
Insurance Types, n (%):      
Medicare/ Medicare HMO 11,380 (49.92) 10,993 (47.76) 135,021 (48.61) 157,394 (48.64) *** 
Medicaid/ Medicaid HMO 466 (2.04) 307 (1.33) 3,091 (1.11) 3,864 (1.19) *** 
Indemnity/ Commercial  10,180 (44.65) 11,226 (48.77) 132,672 (47.76) 154,078 (47.62) *** 
Self pay/Charity/Other 771 (3.38) 493 (2.14) 6,985 (2.51) 8,249 (2.55) *** 
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Unadjusted rates of serious GI adverse events for all and specific polypectomy 
procedures were calculated and increased with the rise in complexity of polypectomy procedures 
for each endoscopist specialty (Table 2). The rate of increase in adverse events was the lowest 
for gastroenterologists in comparison with both primary care providers and surgeons. Unadjusted 
rates of serious adverse events were the highest for primary care endoscopists providing complex 
colonoscopy.  
 
Table 2. Unadjusted Rates of Serious GI Adverse Events per 1,000 Polypectomies by Procedure 
Type and Endoscopist Specialty  
 Primary Care Surgery Gastroenterology 
All procedures 4.343 (3.531 - 5.285) 3.910 (3.145 - 4.804) 3.546 (3.328 - 3.774) 
Cold biopsy forceps 1.397 (0.603 - 2.750) 2.417 (1.106 - 4.584) 1.319 (1.052 - 1.632) 
Hot biopsy forceps/Ablation  3.106 (1.991 - 4.617) 3.216 (2.201 - 4.537) 3.341 (2.955 - 3.764) 
Snare polypectomy 5.758 (4.036 - 7.963) 4.927 (3.302 - 7.068) 4.507 (4.075 - 4.973) 
Complex Colonoscopy 10.036 (6.829 - 14.215) 5.780 (3.534 - 8.913) 5.173 (4.535 - 5.875) 
 
Multivariate Analyses: 
Table 3 reports the likelihood of receiving each type of polypectomy by endoscopist 
specialty and endoscopist polypectomy volume, controlling for other covariates.  Compared to 
gastroenterologists, the odds ratios for using cold biopsy forceps were significantly greater for 
primary care endoscopists (1.12 [95%CI, 1.09 to 1.16]) and lower for surgeons (0.61 [95%CI, 
0.59 to 0.63]).  The odds ratios for using hot biopsy forceps/ablation were greater for primary 
care providers (1.20 [95%CI, 1.17 to 1.24]) and surgeons (1.84 [95%CI, 1.79 to 1.90]) relative to 
gastroenterologists. The odds for using snare polypectomy and complex colonoscopy procedures 
were lower for non-gastroenterologists than for gastroenterologists (Table 3).  Low-volume 
endoscopists were more likely to use cold biopsy forceps, and hot biopsy forceps/ablation - and 
were less likely to use snare polypectomy and complex colonoscopy procedures than high-
16 
 
volume providers (Table 3).  Polypectomy rates increased for endoscopists who used hot biopsy 
forceps/ablation and complex colonoscopy procedures; however, the use of cold biopsy and 
snare polypectomy was associated with decreased polypectomy rates (Table 3).  Cold biopsy 
forceps and complex colonoscopy were procedures of choice for repeat endoscopy.  Hot biopsy 
forceps/ablation polypectomy was less likely used for repeat endoscopy (Table 3).  
 
Table 3. Odds Ratios (95% Confidence Intervals) from Multivariate Logistic Regression 
Analyses of Use of Polypectomy Procedures for Endoscopist Specialty and Volume Categories.† 
†All models statistically controlled for differences in facility type, patient demographic characteristics, 
severity of illness, comorbidities, health insurance types, and the year of a procedure.  
***: p<0.01  
 
In a stratified multivariate analysis of cold biopsy forceps (Table 4), neither endoscopist 
specialty types nor volume categories were statistically different from referent groups in terms of 
the odds of adverse events.  For hot forceps biopsy/ablation, the odds ratios of serious adverse 
events were not statistically significantly different for endoscopist specialties; however, low- 
(1.61 [95%CI, 1.16 to 2.24]) and medium-volume (1.43 [95%CI, 1.07 to 1.90]) endoscopists 
reported higher odds of adverse events relative to high-volume providers.  Similarly for snare 
polypectomy, the endoscopist specialty did not contribute to increased odds of adverse events, 
but high-volume providers had lower odds of adverse events.  For complex colonoscopy, low-
volume providers (1.45 [95% CI, 1.05 to 2.01]) reported higher odds of adverse events relative to 
 
Cold biopsy forceps 
(n=73,151) 
Hot biopsy 
forceps/Ablation 
(n=98,486) 
Snare polypectomy 
(n=99,776) 
Complex Colonoscopy 
(n=52,172) 
Primary care  1.123 (1.086 - 1.161) *** 1.201 (1.166 - 1.237) *** 0.844 (0.818 - 0.870)*** 0.827 (0.795 - 0.862)*** 
Surgery 0.608 (0.585 - 0.632)*** 1.842 (1.791 - 1.896)*** 0.690 (0.668 - 0.712)*** 1.023 (0.983 - 1.065) 
Gastroenterology 1 1 1 1 
Volume < 150 1.100 (1.072 - 1.128)*** 1.158 (1.132 - 1.185)*** 0.868 (0.848 - 0.888)*** 0.836 (0.812 - 0.861)*** 
Volume 150 - 299 0.990 (0.970 - 1.011) 1.088 (1.068 -1.109)*** 0.972 (0.954 - 0.99)*** 0.898 (0.877 - 0.919)*** 
Volume > 300 1 1 1 1 
Polypectomy rate 0.286 (0.269 -  0.305)*** 1.823 (1.729 - 1.922)*** 0.257 (0.244 - 0.272)***  12.975 (12.145 -  13.862)***  
Repeat endoscopy 1.175 (1.106 - 1.248)*** 0.761 (0.720 - 0.806)***  0.991 (0.940 - 1.046)  1.235 (1.160 - 1.314)***  
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high-volume endoscopists  Finally, higher odds of adverse events were reported for primary care 
endoscopists (1.74 [95%CI, 1.18 to 2.56]) relative to gastroenterologists for complex 
colonoscopy. There were no differences in odd ratios reported for surgeons in comparison with 
gastroenterologists after complex colonoscopy.  Neither polypectomy rate nor repeat endoscopy 
was associated with increased odds of serious adverse events. 
Table 4. Odds Ratios (95% Confidence Intervals) from Multivariate Logistic Regression Analyses of 
Serious GI Adverse Events for Endoscopist Specialty and Volume Categories, Stratified by Polypectomy 
Procedure.† 
†All models statistically controlled for differences in facility type, patient demographic 
characteristics, severity of illness, comorbidities, health insurance types, and the year of a 
procedure. 
 
***: p<0.01,**: p<0.05 
 
Discussion 
About half of all colonoscopy procedures are polypectomies [15]. Polypectomy is 
important for CRC prevention, but is associated with adverse events.  While adverse events after 
polypectomy are rare, they are serious and life threatening [16]. The colonic perforation is the 
most serious adverse event with reported rates of 0.1% - 0.3% and a fatality rate of 5% [16]. 
Gastrointestinal (GI) bleeding is the most common serious adverse event with reported risks of 
0.1% - 0.6% [16]. Polypectomy was associated with up to a nine-fold increase[12-14] in risks of 
serious adverse events when compared to a relatively safe diagnostic colonoscopy [16-17]. 
Characteristics 
Cold biopsy forceps 
(n=73,151) 
Hot biopsy 
forceps/Ablation 
(n=98,486) 
Snare polypectomy 
(n=99,776) 
Complex Colonoscopy 
(n=52,172) 
     
Primary care 0.965 (0.457, 2.036) 0.847 (0.552, 1.299) 1.174 (0.829, 1.661) 1.740 (1.183, 2.559) *** 
Surgeon 1.526 (0.740, 3.146) 0.884 (0.605, 1.292) 1.041 (0.704, 1.540) 0.970 (0.607, 1.551) 
Gastroenterology 1 1 1 1 
Volume < 150 1.363 (0.774, 2.398) 1.607 (1.155, 2.237)*** 1.366 (1.025, 1.821)** 1.450 (1.046, 2.009)** 
Volume 150 - 299 1.143 (0.699, 1.870) 1.429 (1.073, 1.903)** 1.397 (1.112, 1.756)*** 0.852 (0.633, 1.146) 
Volume > 300 1 1 1 1 
Polypectomy rate 0.480 (0.111 - 2.087)   1.512 (0.728 - 3.139)  1.442 (0.707 - 2.942)   1.200 (0.564 - 2.556)  
Repeat Endoscopy 0.507 (0.070 - 3.651)   0.494 (0.158 - 1.544)   0.463 (0.192 - 1.121)   0.250 (0.062 - 1.006) 
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Reported risks of adverse events increased, as the complexity of polypectomy procedures has 
heightened [12]. Similarly to previous findings, this study’s reported rate of the colonic 
perforations and GI bleeding is 0.4%.  The current study also suggests that the complexity of 
polypectomy procedures may contribute to increased risks of adverse events for endoscopists in 
different specialty groups.   
The current study is the first to investigate the use of specific polypectomy techniques for 
primary care, surgery, and gastroenterology endoscopists, endoscopist volume categories, and to 
identify associated odds ratios for serious GI adverse events.  We also observed important trends 
in the use of polypectomy techniques by endoscopist specialty and experience.  Primary care 
endoscopists and surgeons were more likely to use hot biopsy forceps/ablation for polyp or 
lesion removal in comparison with gastroenterologists.  In addition, gastroenterologists provided 
more snare polypectomy and complex colonoscopy procedures than non-gastroenterologists.  
The high-volume endoscopists were more likely to provide complex colonoscopies. 
Polypectomy rates were higher for endoscopists who used hot biopsy forceps/ablation and 
complex colonoscopy procedures.  Cold biopsy forceps and complex colonoscopy were 
procedures of choice for repeat endoscopy.  It is expected that complex colonoscopy is used for 
detection and removal of adenomas that vary in location, types, multiplicity, and size during the 
initial and repeat endoscopy.  Cold biopsy forceps are likely to be used in repeat endoscopy to 
assure a complete adenoma removal.  However, a use of hot biopsy forceps for initial endoscopy 
require additional research as the experts recommended cold snare polypectomy instead of hot 
biopsy forceps.  
Our study found that endoscopists in all specialty and volume categories could safely use 
cold biopsy forceps.  These findings corroborate the literature suggesting that cold polypectomy 
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techniques are the safest in terms of risks of serious GI adverse events [12,24].  More research is 
warranted on cold polypectomy techniques and post-colonoscopy CRC, as some studies reported 
that residual polyp tissues were discovered after cold forceps [25-26]. Our study also identified 
that endoscopist volume, but not specialty, may be associated with reduced risks of serious GI 
adverse events after hot biopsy forceps/ablation and snare polypectomy.  On the other hand, 
endoscopist specialty, but not volume, may contribute to reduction of the risks of serious adverse 
events after complex colonoscopy, as higher odds of adverse events were reported for primary 
care providers relative to the odds of adverse events reported for gastroenterologists and 
surgeons.  Patient outcomes were comparable for surgeons and gastroenterologists. 
For primary and single procedures requiring either polypectomy via hot biopsy 
forceps/ablation or snare polypectomy, an annual volume of 300 or more polypectomies was 
important for reduction of serious adverse events.  The European guidelines on colonoscopy 
volume recommend a 300-volume threshold [27]. Our findings suggest that hot biopsy/ablation 
or snare polypectomy techniques may be improved as endoscopists provide higher volumes of 
these types of procedures.  In terms of snare polypectomy, these findings may correspond well 
with recommended by the American College of Gastroenterology practices of cold snare 
techniques over electrocautery polypectomy [28]. However, additional research on the value of 
polypectomy via hot biopsy forceps/ablation is needed specifically for non-gastroenterologists 
who tend to use more of this type of polypectomy in comparison with gastroenterologists.  
An endoscopist specialization in gastroenterology or surgery and annual polypectomy 
volume greater than 150 procedures are important for reducing the rates of serious GI adverse 
events after complex colonoscopy.  Complex colonoscopy is effective for detecting polyps and is 
often used for repeat endoscopy. Complex colonoscopy may involve a combination of several 
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polypectomy techniques performed during the same session when multiple polyps or lesions of 
various sizes and types are likely to be removed.  Previous research suggested that primary care 
physicians were less likely to use complex gastrointestinal procedures [5], and confirmed by our 
findings.  Differences in duration and intensity of training in endoscopy for primary care 
endoscopists may explain this finding.  As such, primary care endoscopists may require cross-
training and/or continuing medical education in complex colonoscopy techniques to prepare for 
the growing demand of polypectomy due to the aging population in the U.S.  
The study has limitations.  We used historic data for the period 1999-2001.  However, the 
studied polypectomy techniques are still widely used by endoscopists, and a slow adoption of 
new techniques, e.g. micro-clips, has been reported [14]. As such, our findings provide relevant 
baseline data for the future research on the impact of endoscopist specialty and polypectomy 
techniques on various patient outcomes.  Although the study is population-based, it is restricted 
to a single state.  New research utilizing newer datasets from additional states is warranted.  A 
lack of access to patients’ medical records to fully adjust for the quality of bowel preparation or 
prior use of medications (e.g., anticoagulants or antibiotics), especially by elderly patients, was a 
limitation.  In addition, data were not available to include adverse events associated with 30-day 
ER visits and colonoscopies provided in physician offices.  The study’s data did not distinguish 
between GI bleeding potentially unrelated to polypectomy (e.g., bleeding from hemorrhoids, 
diverticula, or due to radiation proctitis, or other entities.  However, the serious GI adverse 
events requiring inpatient admission were procedure specific and may have occurred due to 
medical errors.  The data did not capture the few patients with colonoscopy-related adverse 
events who were hospitalized outside the state of Florida and those who were treated in 
physician offices.  It is unlikely that many polypectomy procedures would be carried out in 
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physician offices.  The data did not include information on endoscopists’ age, years of practice, 
affiliation with academic centers, and other experiences that may potentially affect the rate of 
adverse events.  There was also no information on lesion type, polyp size and multiplicity in the 
dataset.  As such, there may be potential confounding between polyp or lesion type/size, multiple 
polyps, and choice of polyp removal technique.  However, we used a validated risk adjustment 
approach that accounted for both severity of current illness (e.g., a polyposis) and comorbidities. 
More research utilizing newer datasets from additional states and clinical information is needed 
to better understand which type of polypectomy, endoscopist specialty and experience, are 
preferred for increasing adenoma detection rates, and reducing rates of adverse events and post-
colonoscopy CRC.  In addition, because change in endoscopy practices might require a 
considerable amount of time, additional research on barriers for adoption of new practices, such 
as awareness of and compliance with the colonoscopy guidelines across endoscopist specialties, 
is important to consider.  
Nevertheless, this research has several implications for clinical practice and policy.  We 
analyze all-encounter, all payer data covering the entire population of Florida for a three-year 
period. This provides an important advancement over previous studies that examined a limited 
number of facilities or health systems, used restricted datasets such as Medicare or Medicaid-only 
data, or were non-US-based.  Our database is unique as it reports UPINs for each endoscopists 
allowing us to construct a measure of endoscopist specialty, and to report a use of polypectomy 
procedures and rates of adverse events by endoscopist characteristics.  
 
We believe our study is the first to report important variations in the use of polypectomy 
techniques.  We found  that non-gastroenterologists and low-volume endoscopists tend to 
perform simpler procedures than gastroenterologists.  The risk of serious adverse events is small 
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for cold biopsy forceps procedures and independent of endoscopist specialty and experience.  
Thus, cold biopsy forceps is a safe procedure that may be widely used in clinical practice of 
primary care endoscopists, surgeons, and gastroenterologists. A technical proficiency in hot 
biopsy/ablation and snare polypectomy is achievable with experience (i.e., increased volume) for 
endoscopist in all specialty categories.  Providing more than 300 polypectomy procedures 
annually may be an important benchmark for improving endoscopists experience and achieving 
proficiency in polypectomy. Surgeons, gastroenterologists, and higher-volume providers had 
lower rates of adverse events than primary care and low-volume  endoscopists (i.e., providing 
less than 150 procedures annually) for complex colonoscopy.  As such, some cross-training and 
continuing medical education in complex polypectomy techniques for primary care endoscopists 
in high-volume settings may be considered. 
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